CIT | CIT

CIT is an ultra-specialized partner in secondary packaging—the last mile of the manufacturing process, where precision, customization, and control are critical.For over 40 years, CIT has supported pharmaceutical companies, MAHs, and CDMOs in the most sensitive phase of the production lifecycle: the moment when a product becomes market-ready, in full compliance with local and international regulatory requirements.The company’s identity is built on quality, reliability, and executional precision. Secondary packaging is not viewed as a mere operational task, but as a critical process with significant regulatory and reputational impact. Within this framework, CIT Pharma integrates serialization, track & trace systems, multi-country artwork management, and rigorous documentation control—ensuring full alignment with the requirements of leading international regulatory authorities.CIT operates as an operational and regulatory extension of its clients, delivering tailored solutions for both clinical and commercial projects. The organization is structured to manage small, high-complexity batches as well as industrial-scale volumes, while maintaining high GMP standards and a robust quality assurance system. Particular attention is given to mix-up risk mitigation, full product traceability, and optimized time-to-market.With cross-functional experience across multiple therapeutic categories and storage requirements, CIT Pharma supports products with particularly stringent regulatory and logistical demands—including temperature-controlled medicines, high-potency drugs, and therapies intended for niche indications.For MAHs and CDMOs, CIT Pharma represents a strategic partner capable of combining technical expertise, regulatory strength, and international vision—transforming secondary packaging into an enabling step for fast, secure, and fully compliant access to global markets.